SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 16

SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ECOMANN. The owner is based in SHENZHEN.

1/F, ROOM 108, 109, 110, 111, 112

SHENZHEN 518067 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AMBIO
AMBIO
Cancelled 2013
ECOMANN
ECOMANN
Registered 2009

Trademark Classifications

SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD. have?

SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD. file in?

SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD.'s most well-known trademarks?

SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as ECOMANN. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD.'s trademark registration success rate?

SHENZHEN ECOMANN BIOTECHNOLOGY CO., LTD. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.